China (Mainland)
Premiumsupplier
4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile; CAS NO.1165910-22-4
- Min.Order: 100 Metric Ton
- Payment Terms: L/C,T/T,MoneyGram,Other
- Product Details
Keywords
- 1165910-22-4
- 4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile; seller in China
- Sell high quality 1165910-22-4 produced in China factory
Quick Details
- ProName: 4-((R)-2-((R)-2,2,2-trifluoro-1-hydrox...
- CasNo: 1165910-22-4
- Appearance: white crystalline powder
- Application: Food/Medicine/Industria grade
- DeliveryTime: Within 3-7 days after receipt of your ...
- PackAge: As customer request
- Port: QINGDAO CHINA
- ProductionCapacity: 100 Metric Ton/Day
- Purity: 98%min
- Storage: Store in a cool,dry place and keep awa...
- Transportation: Common products:Sea/Air/Courier Dange...
- LimitNum: 100 Metric Ton
Superiority
Details
Details
Lgd-4033 Specification:
| Product Name | Lgd-4033 |
| Lgd-4033 Alias | Ligandrol |
| Lgd-4033 CAS | 1165910-22-4 |
| Lgd-4033 Molecular Formula | C14H12F6N2O |
| Lgd-4033 Molecular weight | 338.2482992 |
| Apperance | White Powder |
| Assay | 99% |
| Grade | Pharmaceutical Grade |
| Delivery time | 12h after your payment |
| Packing | Discreet package for delivery guarantee! |
| Delivery terms | HKEMS,DHL,TNT,EMS,Fedex,UPS |
| Payment | , Money gram, T/T,Bitcoin |
Lgd-4033 Description:
LGD-4033 is one of the newer SARMS that has come out. LGD-4033 is a non-steroidal oral SARM that binds with AR which produces steroid-like results minus the steroids. LGD-4033 is the closest SARM that can be equated to an anabolic in terms of strength. LGD-4033 is the strongest of all the SARMS in terms of the size you can gain.
It's in a group of androgen receptor (AR) ligands that are tissue selective, created to cure muscle wasting linked with acute and chronic diseases, age-related muscle loss and cancer. LGD-4033 is anticipated to yield the healing benefits of testosterone with better safety, admissibility and patient acceptance due to tissue-selective mechanism of action and its oral form of administering.
The use of LGD-4033:
